Literature DB >> 6150300

131I-MIBG and medullary carcinoma of the thyroid.

J M Connell, T E Hilditch, A Elliott, P F Semple.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150300     DOI： 10.1016/s0140-6736(84)92819-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.

Authors:  G Lupoli; G Lombardi; N Panza; B Biondi; G Pacilio; S Lastoria; M Salvatore
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 2.  Drug therapy alternatives in the treatment of thyroid cancer.

Authors:  M J O'Doherty; A J Coakley
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 3.  Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1994-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.